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Abstract 
Teams are the principal vehicle in developing new drug development strategy and 
executing the tasks required to accomplish those objectives.  This project evaluated the 
key drivers for team innovation performance (defined as outcomes).  Team outcomes 
included new information creation, compression of development time, expansion of 
image, learning, capability development, growth satisfaction, and overall effectiveness.  
The two key research questions related to how team innovation performance are 
assessed in the branded pharmaceutical industry, and what the drivers for optimal team 
performance outcomes were.  Results revealed that while good correlations individually 
existed between team outcomes (dependent variable) and tested independent variables 
(autonomy, coaching, climate, proactive personality, empowering leadership, and 
transactive memory systems), the best predictors identified through multivariate 
regression analysis were leader and peer coaching and transactive memory systems.  
The implications of these findings are examined and specific recommendations 
proposed.  The limitations and avenues for further research are elaborated.   
Introduction 
Cross functional project teams offer the structural and functional vehicle in the R&D 
process, as they span various functional disciplines and continuum of time and 
space.   These cross functional teams are often composed of critical functional 
representatives and are chartered with the development of both the strategy and 
the tactical execution of pre-defined agreed upon deliverables.  The members of the 
team represent their home functions but are accountable to the project leaders or 
liaisons that interface with broader organization.  Each team is governed by a 
specific scientific management committee that endorses the strategy and monitors 
the outputs as the project team reaches a predefined milestone.  It is at this team 
level where there is an in-ĚĞƉƚŚĂŶĂůǇƐŝƐŽĨƚŚĞĐŽƌĞƐƚƌĂƚĞŐŝĐŝƐƐƵĞƐ ?ƚŚĞ “ǁŚĂƚ ?ĂŶĚ
ƚŚĞ “ŚŽǁ ? ?ŚĂƉƉĞŶ ? 
 3 
 
Membership on teams is primarily assigned by the functional areas.  Higher the 
assigned priority of the product in question, greater is the need on part of functional 
departments to provide their most knowledgeable and experienced representatives.  
Leadership of teams is similarly done, and project leaders could come from the 
assigned functions that are considered core on teams or from an independent senior 
leadership function.  Thus, the type of teams usually conforms to the definition of 
ůĂƌŬ ĂŶĚ tŚĞĞůƌŝŐŚƚ ?Ɛ(1992) typology.  Because of organizational diversity, the 
team is a good central point where functions interact.  The organizational proximity 
that occurs in teams allows for critical inputs to be shared much early in the process, 
than may otherwise occur in the absence of these project teams.  Moreover, these 
teams focus on milestone oriented, highly focused and time-sensitive tasks.   
While teams are formed by senior management, and have the flavor of top-down 
hierarchical systems, teams are intended to function autonomously, are expected to 
be nimble, and expected to self-operate in flexible working cultures.  In practice, 
however, there is large variability in how this is implemented.  Depending on the 
nature of teams, priority of the project, and the complexity of the issues at hand, 
teams may function independently or with considerable oversight.   More 
experienced the membership, greater is the trust on the team.  Thus, transactive 
memory system (TMS; Wegner, 1987) is a critical determinant of outcomes.  More 
recently, there has been increasing emphasis given to size of these teams, and the 
increase in the use of subteams to pursue specialized tasks.  However, in large 
companies that are often super-specialized, there are often large pockets of subject 
matter expertise causing teams to be traditionally large.  Therefore, generation, 
communication, and sharing of tacit knowledge becomes a significant challenge.  
The socio-cognitive aspects of knowledge sharing and learning become significant.  
Because teams do not control resources or budget and have to rely on functional 
departments for resources, there is often a tension between the team and the 
functions as well as with the oversight committees.  Functions may elect to be more 
overbearing on teams and that may result in teams not being empowered.  Thus, 
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team autonomy plays a role in team effectiveness (Breaugh, 1985).  Team decisions 
may be continually questioned, there could be trust issues between the team and 
the functions, teams and their leaders, or the team leaders and the governance 
committees.  Implicit leader behavior of managing the internal and external 
networks, and effective boundary management will be key (Wageman et al., 2005).  
Team leadership, whether participatory or empowering or principally through 
coaching, and the climate under which the team operates all influence team 
innovation and performance (Cohen and Bailey, 1997).   It is essential to fully 
understand the critical success factors that can contribute to team innovation and 
effectiveness in the pharmaceutical industry.   
Two broad categories of teams, defined by scope and degree of innovation and 
creativity are investigated in this project.  These are discovery and development 
teams operating within a large pharmaceutical R&D context.  Discovery teams are 
those teams responsible for the design and execution of the strategy leading up to 
proof of concept in humans, and can span the entire length from target 
identification and lead optimization until Phase IIA of clinical development and those 
teams are governed by the drug discovery and early development research 
committees.  These teams can include heavyweight teams (e.g., early development 
team) and functional (e.g., drug substance and product team) teams.  Development 
teams are those teams responsible for clinical development from Phase IIB through 
registration and licensure of the product and lifecycle management and are 
governed by late development research committee.  These teams can include 
heavyweight teams (e.g., product development team) and functional (e.g., 
preliminary market formulation working group, clinical subteam, regulatory 
subteam, integrated development and supply teams, etc).   
The following drivers for team innovation effectiveness (outcomes) have been 
specifically investigated: 
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x Team autonomy 
x Leader and peer coaching 
x Team climate 
x Proactive personality 
x Empowering leadership 
x Transactive memory systems 
 
Methods 
Survey instruments 
To test the hypotheses, survey questionnaire testing specific dimensions that have 
been previously validated were used for rating by team members.  The 
questionnaires were prepared in an electronic survey software (Qualtrics, licensed 
by Warwick Business School, Coventry, UK), and distributed electronically to 
participants.  Eligible participants belonged to a large pharmaceutical company, and 
were a member of a drug discovery or development team, were mostly scientists, 
engineers, and physicians.  Teams that have overall responsibilities of a set of 
activities within each defined scope of activity and level of the organization, and 
team members being responsible for defining the scope, developing a strategy, and 
executing the deliverables were eligible to participate in this survey.    
Team members may represent a cross section of the leadership in an R&D organization 
and may be a member of any department.  Each survey respondent was requested to 
select an active or recently completed project they were a part of as a member of the 
team.   A total of 75 teams with approximately 500-600 members were contacted.  To 
reduce survey fatigue, a single stage survey was used.  Because eligible teams need to 
be cross-functional in nature, they provide a heterogeneous mix of functional and 
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overarching governance, operating in a wide scope of drug discovery and development 
value chain.   
A total of 13 questions, with multiple sub-parts, as part of 7 key dimensions have been 
adapted from previously validated scales.  These dimensions include team outcomes, 
team autonomy, leader and peer coaching, team climate, proactive personality, 
empowering leadership, and transactive memory system.   Survey respondents were 
prompted to respond to the degree he or she agreed or disagreed using five- to seven-
point Likert scales.  The key variables including the reported internal consistency 
reliability (Cronbach, 1951) are summarized in Table 2. 
Statistical analysis 
All analyses were performed in SPSS version 22 (IBM, licensed from Warwick Business 
School, Coventry, UK).  These analyses included assessing the reliability of the scales 
used in the study, factor analysis, and multi-variate linear regression for testing the 
various hypotheses (Table 1).  Statistical testing of the variables were assessed using a 
two-tailed test at a significance level of 0.05.  No multiplicity adjustment was made. 
Results 
Of the 75 teams contacted (composed of approximately 400-600 team members that 
form those teams), only 190 responded from 43 teams (57% response rate).  Of these 
190 team members, 80 members (42%) were from the discovery phase (from target 
identification to clinical proof of concept) and 110 (58%) were from development phase 
(from clinical phase II through registration and lifecycle management).  These teams 
were staffed by scientists, engineers, and technologists, with a wide variation of first 
degrees to higher doctorates.   
Technology novelty is considered quite relevant in new product development, and 
explains some of the uncertainty and ambiguity teams experience in product 
development.  Nine percent of the respondents indicated there was no new technology 
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involved in the teams, whereas 91% indicated various degrees of technology novelty.  
Interestingly, only 11% indicated that the technology in use was unproven or non-
existing at the start of the project.  Eighty percent indicated that the technology was 
either incremental or pre-existing in some form or another.   
Using the Lynn and Akgun (1998, 2001) typology for innovation novelty, 31% indicated 
the innovation was incremental in nature, 19% indicated it was an evolutionary market 
project, 41% indicated it was an evolutionary technical project, and 9% indicated it was 
a radical innovation project.   
Using Clark and Wheelwright (1992) typology, 24% indicated the structure was a 
functional team grouped by discipline, 44% indicated the structure was a lightweight 
team with a liaison, 23% were part of a heavyweight team with a core group with a 
project leader, and 9% were on an autonomous team with full control of resources.  
These findings are in alignment with the broader organizational context, where there is 
less tolerance to risk and greater control of resources.  The team player style using the 
Parker (1990) typology, showed that a majority of members were collaborators, but only 
8% indicated they were willing to challenge authority and be willing to take risks.   
Validation of reliability of the scales 
A reliĂďŝůŝƚǇĂŶĂůǇƐŝƐǁĂƐƉĞƌĨŽƌŵĞĚŝŶ^W^^ƚŽĞƐƚŝŵĂƚĞƚŚĞƌŽŶďĂĐŚ ?ƐĂůƉŚĂĨŽƌĞĂĐŚŽĨ
the dimensions of the survey study.  Table 3 summarizes the values.  The reliability 
analysis confirms very strong Cronbach (Cronbach, 1951) alpha scores for the previously 
validated scales used in this study, with every scale showing >0.90.   
Factor analysis 
The method of principal component was used for extraction to determine eigenvalues, 
communalities, and factor-loading coefficients.  All questions under each scale were 
evaluated separately, retaining components with significant eigenvalues (>1).  The 
method of rotation chosen was direct oblimin, an orthogonal rotation method, because 
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of expected correlations among factors inherent in behavioral and social science 
research (Costello and Osborne, 2005).   
The measures of appropriateness of the factor analysis included the Kaiser-Meyer-Olkin 
(KMO) measure of sampling adequacy ĂŶĚ ƚŚĞ ĂƌƚůĞƚƚ ?Ɛ ƚĞƐƚ ŽĨ ƐƉŚĞƌŝĐŝƚǇ.  In all 
dimensions, KMO measures were 0.8 or higher, and the ĂƌƚůĞƚƚ ?ƐƚĞƐƚŽĨƐƉŚĞƌŝĐŝƚǇǁĂƐ
significant, indicating that there were correlations within the dataset that were 
appropriate for factor analysis.  An examination of communalities in each variable 
showed that all extracted values were acceptable, indicating reasonable correlation 
between items.  In most cases, one to three factors accounted for a majority (~80%) of 
the variability in all variables.   
Multivariate linear regression 
The pre-specified hypotheses were tested using multivariate linear regression analysis in 
SPSS.  Team outcome was identified as a dependent variable.  Independent variables 
included team autonomy, leader and peer coaching, team climate, proactive 
personality, empowering leadership, and transactive memory systems.  Table 4 
summarizes the descriptive statistics for the composite variables.   
The means were all within the scale ranges of the individual range, with acceptable 
standard deviations.  The sample size of 80 represents completers in survey responses, 
with missing data ignored.  The test of significance of the model was using ANOVA.  
There are a total 79 (N-1) degrees of freedom.  With six predictors, the regression effect 
has 6 degrees of freedom.  The regression effect is statistically significant indicating that 
the prediction of the dependent variable, outcome, is better than can be done by 
chance.  Table 5 is a symmetric correlation matrix that summarizes the standard 
regression results, namely the correlations of the variables (diagonal of the matrix is not 
shown). 
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The prediction model was statistically significant, F(6, 73) = 16.604, p<.001, and 
accounted for approximately 58% of the variance of team outcomes (R
2
 = .577, adjusted 
R
2
 = .542).  The raw and standardized regression coefficients of the predictors along 
with their correlations with team outcomes are shown in Table 6.   
Team outcome was primarily predicted by higher levels of coaching and transactive 
memory systems.  Coaching received the strongest weight in the model, followed by 
transactive memory systems.  Coaching accounts for 9% of the variance of outcome 
whereas transactive memory systems accounts for 5.5% of the variance of outcome.  
Interestingly, climate and personality correlates substantially with outcomes and to 
lesser extent empowering leadership and autonomy, yet in the combination with other 
predictors are not significant predictors in the model.  This is likely because their 
predictive work is being carried out by other variables in the analysis.   
Therefore, the hypotheses that leader and peer coaching (H2) and transactive memory 
systems (H6) are positively correlated with team outcome have been met.  The 
remaining hypotheses were not met, although as indicated above, all others were 
positively correlated albeit not statistically significant.   
Discussion 
Available research has been helpful in identifying key drivers of team effectiveness 
(summarized in Cohen and Bailey, 1997 and Mathieu et al., 2008).  However, each 
organizational context is unique and thus requires a contextually appropriate solution to 
enhancing team innovation and effectiveness.   
In this project, teams are the principal vehicle of the delivery of the main output of 
pharmaceutical industry research and development, namely innovation outputs of new 
drugs and new drug products.  Contextually, therefore, team innovation and 
effectiveness performance is a principal feature of team outcomes.  This is further 
measured as a function of information creation, time compression, image expansion, 
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learning, growth satisfaction, overall effectiveness, and capability development 
(Denison et al., 1996).  For example, innovation and effectiveness in teams can be 
measured by new information creation that would result in intellectual property, 
development time to market and first mover advantage, new learning about a certain 
product or disease expertise, and successfully developing new drugs and line extensions 
(Krishna and Wagner, 2010).   
While reasonably good correlations existed between the various independent variables 
and team outcomes, only two determinants turned out to be statistically significant 
predictors of team outcomes, leader and peer coaching and transactive memory 
systems.   
Baseline evaluations showed that much of the innovation performance in the 
organization were incremental in nature and used some variations of existing 
technology.  These activities were supported by teams that were highly dependent on 
resources from outside of the teams to executive their work.  In fact, only 9% belonged 
to an autonomous team with full control of their resources.  A relative majority of the 
survey respondents belonged to teams which relied on the liaison figure on the team.  
Thus, it is not surprising that leader and peer coaching was a statistically significant 
predictor of team outcomes.  A relative majority of survey participants identified 
themselves as collaborators, again bringing the context of coaching in positive light.   
Because the pharmaceutical industry R&D apparatus is a knowledge intensive 
organization, it is also not surprising that transactive memory systems were also a key 
predictor to team outcomes.  The collective network of knowledge and experience 
curves that exists in individuals and groups within the wider organizational context are 
essential in knowledge encoding, storage, and retrieval (Wegner et al., 1985;  Wegner, 
1987).   
A surprising finding in the project is the lack of statistical significance of proactive 
personality and empowering leadership as a predictor of team outcomes, despite a 
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positive correlation existing between the independent variables and team outcomes.  It 
helps to frame this finding within the wider organizational context.  A diagnostic 
interview conducted with senior leadership in the company revealed that the 
organization has a risk-averse culture.  Part of risk-averse culture relates to decisions on 
funding and milestone movements of projects to be tightly orchestrated by senior 
leadership, which could mean that a culture of empowerment may either not exist or 
appreciated as a positive attribute.  In such a case, this may mean that senior leadership 
is unwilling to relegate decision rights to teams and may partly explain why these 
variables were not a significant predictor for team outcomes.  However, it is also a 
possibility that there may be colleanarity between these two variables and the peer and 
leader coaching, which was a significant predictor, wherein their predictive work is 
being accomplished by peer and leader coaching in the multivariate linear regression 
model.   
A second surprising finding in this study was that team autonomy was not statistically 
significant as a predictor of team outcomes.  This is contrary to an extensive body of 
published literature which indicates team autonomy strongly correlates with team 
performance (reviewed in Cohen and Bailey, 1997).  However, a key underlying 
assumption is that autonomy might depend on the degree of task interdependence.  
Langfred (2005) suggests that there is an optimal level of combination of individual and 
team autonomy which is highly dependent on the level of task interdependence in a 
given team.  For example, autonomous teams that are tasked with highly 
interdependent activities may have appropriate level of infrastructure (i.e., coordination 
and cohesiveness) already in place that contributes to a positive relationship with team 
outcomes.  However, there may be situations where autonomous teams might incur 
additional penalty, such as coordination costs which may negate the value team 
autonomy may have as a significant predictor of team performance.  This is further 
supported by the work of Cummings (1977 a, b) that shows that autonomous teams that 
are less interdependent may actually result in lower performance than teams that 
perform highly interdependent tasks.  Therefore, it is possible that a part of the reason 
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why team autonomy was not significant in this study may relate to the presence of 
significant coordination costs that may have existed in the teams.  Because only a very 
small number of survey participants identified themselves as members of autonomous 
teams, it is not clear whether a higher sample size would have yielded a more 
predictable relationship.   
Another surprising finding was that team climate was also not statistically significant as 
a predictor of team outcomes.  This finding contrasts the findings in the literature which 
argues that climate for innovation is a significant precondition to managing work teams 
involved in knowledge intensive enterprises (Kivimaki et al., 1997; Anderson and West, 
1998).  It is worthwhile to point out that there were considerable change events in the 
wider organizational context that created restlessness in the organization.  Such 
activities may have caused a disruption in the overall climate and the boundary 
conditions under which these teams operated and could explain why team climate was 
not a statistically significant predictor of team outcomes.   
The following sections further discuss the two hypotheses that were met in greater 
detail. 
Leader and peer coaching 
The leader and peer coaching instrument used in this study was a subscale of the team 
diagnostic survey (Wageman et al., 2005), and included such characteristics as focus of 
ůĞĂĚĞƌ ?ƐĂƚƚĞŶƚŝŽŶ ?ĐŽĂĐŚŝŶŐĂǀĂŝůĂďŝůŝƚǇ ?ƚĂƐŬĨŽĐƵƐĞĚƉĞĞƌĂŶĚůĞĂĚĞƌĐŽĂĐŚŝŶŐ ?ŽƉĞƌĂŶƚ
coaching, and interpersonal peer and leader coaching.  When reviewing wider 
organizational context, it is clear that the company had progressed through multiple 
layers of strategic and transformational change.  Thus, a principal role of the leader and 
peer in a team is sensemaking (Wiersema and Bantel, 1992), and navigating through 
evolving emergent change while maintaining focus on team tasks and deliverables  W an 
adaptive change, as a failure to do so could be disruptive to the team and its subtle 
internal dynamics (DeRue et al., 2008).  Existing committees were decommissioned, and 
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new committees were formed within the wider organizational context.  The team 
members viewed and counted on their leader as well as other members of the team to 
make sense of the changes around teams and still carry out tasks and deliverables to 
their overall satisfaction as well as those of their immediate management.  The core role 
a leader plays include coaching, developing and mentoring the team and this has been 
shown to have a positive impact on team performance (Hackman and Wageman, 2005; 
Wageman 2001; Wageman et al., 2005). The leader ensures each team member has 
adequate skills and knowledge to perform that role and there is sufficient emphasis on 
training and coaching of the team members (Kozlowski et al., 1996;  Zaccaro et al., 
2001).  Because the leader on the teams investigated in this project were largely those 
who related with other team members in a liaison role and not as senior leadership, any 
sensemaking behavior leaders exercised was likely not viewed as intrusive by team 
members (Morgeson, 2005).   
Another role leaders have is providing feedback to team members, which helps in 
increasing team learning behavior.  In this regard, the findings in this study are 
consistent with those examined by Gibson and Vermeulen (2003), with the exception 
that the leaders on teams examined here were not in a formal contract with team 
members as to their performance management.  Notably, only 9% of survey participants 
identified themselves as members of autonomous teams, whose leaders have direct 
accountability to team performance and resource assignments.   
Transactive memory systems 
The transactive memory systems scale instrument evaluated specialization, credibility, 
and coordination (Lewis, 2003).  The core aspect of this instrument relies on capturing 
ƚĞĂŵŵĞŵďĞƌƐ ?ĐŽůůĞĐƚŝǀĞĞǆƉĞƌƚŝƐĞ ?ĂĨƵŶĚĂŵĞŶƚĂůĞůĞŵĞŶƚƚŽĂŬŶŽǁůĞĚŐĞŝŶĚƵƐƚƌǇĂƐ
the pharmaceutical industry.  Knowledge in the pharmaceutical industry is a core 
competency, critical to an organizaƚŝŽŶ ?ƐƐƵƐƚĂŝŶĞĚĐŽŵƉĞƚŝƚŝǀĞĂĚǀĂŶƚĂŐĞ ?WƌĂŚĂůĂĚĂŶĚ
Hamel, 1990).  Knowledge resource is an inherent dynamic capability (Teece et al., 
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1997), the intangible synergy that ensues when a group of scientists, physicians, and 
engineers collaborate to solve tangible medical need problems, a requisite for new drug 
product development.   
Transactive memory system was a statistically significant predictor of team outcomes.  
This comes as no surprise given the knowledge intensive nature of the industry, but is 
more strongly relevant given the current organizational context.  The teams surveyed in 
this study witnessed change events that resulted in significant disruption of knowledge 
activities (e.g., as a result of reorganizations and/or mergers and acquisitions), including 
a mix of planned separations and unintended employee turnover, and elimination of 
redundant sites.  Thus, the knowledge transfer aspect from one project team to another 
was a significant consideration.  Managing that knowledge transfer with minimal loss of 
expertise was a key organizational goal.   
tĞŐŶĞƌ  ? ? ? ? ? ? ĚĞĨŝŶĞƐ dD^ ĂƐ  “ƚŚĞ ĐŽŽƉĞƌĂƚŝǀĞ ĚŝǀŝƐŝŽŶ ŽĨ ůĂďŽƌ ĨŽƌ ůĞĂƌŶŝŶŐ ?
ƌĞŵĞŵďĞƌŝŶŐ ? ĂŶĚ ĐŽŵŵƵŶŝĐĂƚŝŶŐ ƌĞůĞǀĂŶƚ ƚĞĂŵ ŬŶŽǁůĞĚŐĞ ? ? tŚĞƌĞĂƐ tĞŐŶĞƌ
originally intended to apply TMS to long tenured employee groups, tenure is not 
necessarily the principal component of TMS.  Rather, the intangible undefined synergy 
that exists in collective foresight during problem solving in group creativity is also an 
inherent feature of TMS (Akgun et al., 2006; Dayan and Basarir, 2010; Gino et al., 2010).  
>ĞǁŝƐ ?  ? ? ? ? ? ?ĚĞĨŝŶĞƐĂdD^ĂƐƚŚĞ  “ĂĐƚŝǀĞƵƐĞŽĨƚƌĂŶƐĂĐƚŝǀĞŵĞŵŽƌǇďǇƚǁŽŽƌŵŽƌĞ
ƉĞŽƉůĞ ƚŽĐŽŽƉĞƌĂƚŝǀĞůǇƐƚŽƌĞ ?ƌĞƚƌŝĞǀĞ ?ĂŶĚĐŽŵŵƵŶŝĐĂƚĞ ŝŶĨŽƌŵĂƚŝŽŶ ? ? ŽƚŚtĞŐŶĞƌ
and Lewis underscore the cooperative cognitive systems that describe the intangible 
synergy in teams.  TMS helps understand how effective teams apply based on known 
knowledge.  TMS was a good predictor of team outcomes, and implicitly, this means 
that members of higher performing teams specialize in different but complementary 
domains such that there is a higher order task specific knowledge applied to defined 
tasks.  Another valuable insight gained is when staffing new teams, more the 
complementarity of the expertise, greater likelihood there is to develop TMS rapidly.   
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Other authors point out that the TMS is a repository of knowledge that transcends 
teams, to the wider organizational context (Walsh and Ungson, 1991).  However, the 
teams are tightly integrated within the broader organizational context, at least in the 
sample examined in this study, so it is assumed that team memory is a good surrogate 
of organizational memory.  This assumption may be limited in cases where the TMS is 
tightly linked to a mass group of departing employees, and the project team is then 
replaced as a whole.  The work of Lewis et al. (2007), suggests that although group 
performance may vary between partially intact groups and intact groups if there is not 
an adaptation that occurs to correct inefficient TMS processes.   
Conclusions 
This research offers key insights for managers when forming and staffing teams.   
One is an emphasis on coaching.  It is imperative for senior managers to assign 
individuals to teams who liaise with broader management that are capable of offering 
coaching and availability for team members to enhance their skills.  This is particularly 
important in a growing hypercompetitive environment which is witnessing continuous 
strategic change.  Thus, a capable leader is one who provides coaching to the team 
members, as well as helps them reach their growth potential as well as skills that will 
help with adapting to a continuously changing organizational context.  The leader also 
favorably enables peer coaching.  Importantly, the leader should have interpersonal 
skills that are not viewed as intrusive to team psyche and dynamics.  Preferably, a team 
member who has been on the team as a peer and has evolved leadership skills, and who 
has gained the wider trust by peers, should be considered as a team leader.   
A second area of emphasis is on transactive memory systems.  As this is a central driver 
to team performance, it is imperative to improve adaptation skills of team members.  
Particularly, in cases where there is anticipated to be a disruption to team membership, 
effort would need to be given to preserve the inner core of the team so that there is 
sufficient time available for learning by a new team member.  Complete reconstitution 
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of a team would be considered disruptive to TMS processes and thus preferable to 
avoid.   
Limitations and Future Research Directions 
One of the limitations of this study was the relatively small sample size.  While the 
response rate was satisfactory, samples were drawn from a single large pharmaceutical 
company to ensure a single frame organizational context.  A relative majority of the 
survey participants identified with incremental innovation and technology novelty, 
precluding subset analysis between teams that focused on incremental and radical 
innovation.  Although the study yielded valuable insights on drivers of team outcomes, 
this precluded more sophisticated analysis including path dependencies and subset 
analysis of the various dimensions as a function of team structure, innovation type, and 
technology novelty.  One future research direction would be to study the team 
outcomes in a large diversity of pharmaceutical enterprises, of varying firm size and 
organizational context.   
Because the leaders on the teams investigated in this project were largely those who 
related with other team members in a liaison role and not as senior leadership inherent 
in autonomous teams, whether some of the leader behavior was considered intrusive by 
team members could not be studied (Morgeson, 2005).  Thus, a second possible future 
research direction would be to study the role of senior leaders as team leader, where 
there is at least a gap of 3-4 managerial tier level difference between leaders and team 
members.   
As indicated above, because the sample size was not large enough to provide balance to 
the type of team structures, no attempt was possible to relate how TMSs operate in 
teams of differing team structures.  A third aspect to future research on TMSs relate to 
complete reconstitution of group membership and how that affects team outcomes.  
This is particularly applicable to mergers and acquisition situations, where a target 
company is subsumed in the acquirer company infrastructure, and there is a near 
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complete loss of talent either through voluntary or involuntary separations, and there is 
little to no institutional memory on projects.   
A potentially fourth area for future research is to investigate team outcomes 
longitudinally with two-stage surveys, at more than one snapshots of time.  There are 
stage gate milestones as the drug candidate moves form one phase to another (e.g., 
discovery to development), and there is a natural transition between one type of team 
to another.  Because the pharmaceutical industry is a slow innovation industry, where 
the average time span from target identification through marketing can range from 10-
15 years (Paul et al., 2010), such a longitudinal study would have been impossible to 
undertake within the constraints of this program, but nonetheless could offer valuable 
insights to researchers and practitioners.   
A final avenue of future research relates to the role of within-team competition in 
contributing to team knowledge sharing.  This aspect was not studied in this project and 
is worth further study, partly because there is some degree of inherent competition 
within teams in knowledge intensive organizations and partly because there is 
contradictory data in the literature that relates to how significantly affected team 
performance would be (He et al., 2013).   
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LIST OF TABLES 
 
Table 1:  Hypotheses to be tested in the team effectiveness study 
What tested Hypotheses 
Team autonomy on 
outcomes 
H1:  Team autonomy is positively correlated with team 
outcomes 
Leader and peer 
coaching on outcomes 
H2:  Coaching (leader and peer) is positively correlated with 
team outcomes 
Team climate on 
outcomes 
H3:  Team climate is positively correlated with team outcomes 
Proactive personality 
on outcomes 
H4:  proactive personality is positively correlated with team 
outcomes 
Empowering 
leadership on 
outcomes 
H5:  empowering leadership behavior is positively correlated 
with team outcomes 
Transactive memory 
system on outcomes 
H6:  Transactive memory systems is positively correlated with 
team outcomes 
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Table 2:  Summary of validated scales and their reliability indices 
 
Variable Definition Measurement 
scale 
Internal 
consistency 
reliability 
(alpha) 
Reference 
Team 
outcomes 
Information creation 
Time compression 
Image expansion 
Learning 
Growth satisfaction 
Overall effectiveness 
Capability development 
5-point Likert 
scale 
0.84 
0.75 
0.82 
0.73 
0.84 
0.76 
0.78 
Denison, 
Hart, and 
Kahn, 1996 
Team 
autonomy 
Global work autonomy scale 
Method 
Schedule 
Criteria  
7-point Likert 
scale 
 
0.91-0.92 
0.81 
0.77-0.83 
Breaugh, 
1985 
Leader and 
peer 
coaching 
Team diagnostic survey 
Leader and peer coaching 
subscale 
5-point Likert 
scale 
 
0.92 
Wageman, 
et al., 2005 
Team 
climate 
 
Team Climate Inventory 
Innovation subscale 
5-point Likert 
scale 
0.83-0.94 
0.90 
Kivimaki et 
al., 1997; 
Anderson 
and West, 
1998 
Proactive 
personality 
Proactive behavior 7-point Likert 
scale 
0.89 Bateman 
and Crant, 
1993 
Empowering 
leadership 
Meaningfulness 
Participation in decision making 
Confidence in high performance 
Autonomy to bureaucratic 
constraints 
5-point Likert 
scale 
0.89 
0.86 
0.85 
0.79 
Ahearne, 
Mathieu, 
and Rapp, 
2005 
Transactive 
memory 
system 
Specialization 
Credibility 
Coordination 
5-point Likert 
scale 
0.80-0.84 
0.81-0.83 
0.78-0.83 
Lewis, 2003 
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Table 3 ?ƌŽŶďĂĐŚ ?Ɛ(Cronbach, 1951) alpha for survey components 
Component Number of 
scale items 
Valid N Cronbach alpha 
Team outcomes 22 163 0.985 
Team autonomy 9 182 0.928 
Leader and peer coaching 26 169 0.982 
Team climate 8 158 0.984 
Proactive personality 17 156 0.985 
Empowering leadership 12 156 0.993 
Transactive memory systems 15 156 0.973 
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Table 4:  Descriptive statistics 
Composite scale Mean 
Std. 
Deviation N 
Outcomes 3.5278 .38566 80 
Autonomy 5.2083 .96239 80 
Coaching 3.2577 .49214 80 
Climate 3.7063 .60917 80 
Personality 5.1735 .86957 80 
Empowering Leadership 3.6979 .66116 80 
Transactive Memory 
Systems 
3.6433 .28465 80 
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Table 5:  Summary of the correlations of the variables in the analysis (N=80) 
Variable 2 3 4 5 6 7 
Outcomes .386 .579 .571 .538 .469 .583 
Autonomy -- .342 .530 .161 .506 .285 
Coaching  -- .452 .345 .628 .260 
Climate   -- .495 .572 .535 
Personality    -- .305 .600 
Empowering 
Leadership 
    -- .397 
TMS      -- 
Note:  All correlations except that between personality and autonomy (p=.076), 
autonomy and TMS (p=.005), coaching and TMS (p=.010), and personality and 
ĞŵƉŽǁĞƌŝŶŐůĞĂĚĞƌƐŚŝƉ ?Ɖс ? ? ? ? ?ǁĞƌĞƐƚĂƚŝƐƚŝĐĂůůǇƐŝŐŶŝĨŝĐĂŶƚ ?Ɖч ? ? ? ? ? ? 
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Table 6:  Summary results for standard regression 
Model 
Unstandardized 
Coefficients 
Beta t Sig. 
Pearson 
r 
Correlations  
sr
2
 
b SE-b Partial Part 
(Constant) .231 .411  .562 .576     
Autonomy .041 .038 .103 1.085 .282 .386 .126 .083 .007 
Coaching* .313 .079 .400 3.948 .000 .579 .419 .301 .09 
Climate .089 .071 .141 1.254 .214 .571 .145 .095 .009 
Personality .066 .045 .149 1.463 .148 .538 .169 .111 .012 
Empowering 
Leadership 
-.051 .066 -.087 -.766 .446 .469 -.089 -.058 
.003 
Transactive 
Memory 
Systems* 
.432 .140 .319 3.091 .003 .583 .340 .235 
 
.055 
Note:  the dependent variable was outcomes.  R
2
 = .577, adjusted R
2
 = .542.  *p < .05.  
sr
2
 is the squared semi-partial correlation. 
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